Analysts' Actions: MDP NDSN RFMD RP TQNT

NEW YORK (TheStreet) -- CHANGE IN RATINGS

AllianceBernstein (AB) was upgraded to buy at TheStreet Ratings.

Meredith (MDP) was upgraded at Benchmark to buy from hold. Twelve-month price target is $52. TV acquisitions are shifting the mix positively toward broadcasting, Benchmark said.

Nordson (NDSN) was upgraded at Oppenheimer to outperform from perform. Twelve-month price target is $85. Significant investments in future growth should pay off in the long run, Oppenheimer said.

RF Micro Devices (RFMD) was downgraded at Canaccord Genuity to hold. Valuation call, based on a 12-month price target of $7.25, Canaccord Genuity said.

RF Micro Devices was downgraded at DA Davidson to neutral from buy. Valuation call, based on a 12-month price target of $7.

RealPage (RP) was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is $22. Company cut guidance and is seeing higher sales force turnover, RBC Capital said.

RealPage was downgraded to hold at TheStreet Ratings.

TriQuint (TQNT) was downgraded at DA Davidson to neutral from buy. Valuation call, based on a 12-month price target of $12, DA Davidson said.

Stock Comments / EPS Changes

Calpine (CPN) was cut from the Best Ideas List at Morgan Stanley. Twelve-month price target is $30. Company lacks regulatory clarity in Texas, Morgan Stanley said.

DISH Network (DISH) 12-month price target was increased to $58 at UBS. Valuation call with revised cost of capital assumptions, UBS said. Neutral rating.

EOG Resources (EOG) 12-month price target was raised at UBS to $203. 2014 volume guidance was raised. Buy rating.

Hershey (HSY) 12-month price target was raised to $117 at Credit Suisse. Company can continue to deliver consistent growth across the globe, Credit Suisse said. Outperform rating.

Marriott (MAR) estimates, 12-month price target were boosted at BMO Capital. Price target is now $57. Estimates were also increased, as the company is buying back more shares, BMO Capital said. Market Perform rating.

Allscripts Healthcare Solutions (MDRX) price target was lifted at UBS. PHM demand surging and potential earnings power at HER, UBS said. Twelve-month price target is $19. Neutral rating.

Public Service (PEG) numbers were increased at Credit Suisse. Estimates were raised through 2016. Company boosted its guidance, Credit Suisse said. Neutral rating and new 12-month price target of $35.

Tesla (TSLA) 12-month price target was increased at Morgan Stanley to $320. Company could become a leader in commercializing battery packs, Morgan Stanley said. Overweight rating.

Verizon (VZ) 12-month price target was cut at Credit Suisse to $52. Company is seeing weaker growth, Credit Suisse said. Neutral rating.

Verizon was added to the US 1 List at Bank of America/Merrill Lynch. Company gave positive guidance and remains attractively valued, based on a 12-month price target of $55, BofA/Merrill said.

Zoetis (ZTS) 12-month price target, EPS estimates were cut at Jefferies. Disappointing 2014 guidance and weak livestock market pressures gross margins, Jefferies said. Twelve-month price target is $37. Buy rating.

Follow TheStreet on Twitter and become a fan on Facebook.


This article was written by a staff member of TheStreet.

More from Stocks

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Starbucks Stock Performance in 2018: -12%

Starbucks Stock Performance in 2018: -12%

Burger King Issues Apology After Massive World Cup Promotional Fail

Burger King Issues Apology After Massive World Cup Promotional Fail

The Winners and Losers in Thursday's Market

The Winners and Losers in Thursday's Market